Congress Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-87,941
| Closed | -$2.52M | – | 373 |
|
|
2024
Q2 | $2.52M | Sell |
87,941
-1,021
| -1% | -$29.2K | 0.02% | 264 |
|
|
2024
Q1 | $2.6M | Buy |
88,962
+1,095
| +1% | +$32K | 0.02% | 265 |
|
|
2023
Q4 | $2.96M | Buy |
87,867
+315
| +0.4% | +$10.6K | 0.02% | 272 |
|
|
2023
Q3 | $2.69M | Buy |
87,552
+117
| +0.1% | +$3.59K | 0.02% | 264 |
|
|
2023
Q2 | $3.5M | Buy |
87,435
+1,097
| +1% | +$44K | 0.03% | 248 |
|
|
2023
Q1 | $3.52M | Buy |
86,338
+8,564
| +11% | +$349K | 0.03% | 241 |
|
|
2022
Q4 | $3M | Buy |
77,774
+574
| +0.7% | +$22.2K | 0.03% | 250 |
|
|
2022
Q3 | $4.11M | Buy |
77,200
+35,474
| +85% | +$1.89M | 0.04% | 217 |
|
|
2022
Q2 | $2.43M | Buy |
+41,726
| New | +$2.43M | 0.02% | 262 |
|